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Analysis of Genomic

Introduction
The ´fetal origin´ hypothesis proposes that adulthood hypertension, insulin resistance, dyslipidaemia and non-insulin-dependent diabetes, which are connected to markedly increased rates of cardiovascular disease in adult life, originate through adaptation of the fetus to an early intrauterine environment. It has been suggested that not only maternal nutrition but also maternal exposure to toxins like alcohol, nicotine but also toxins in water and food in early life cause functional and structural changes of the newborn resulting in adulthood hypertension, insulin resistance and dyslipidaemia [1] . Epigenetics serves as an important mechanism capable of regulating gene transcription and linking events early in life to adult morbidity. It is comprised by heritable changes in chromatin that alter gene expression without altering the DNA sequence [2] [3] [4] . Throughout gestation, the placenta plays a crucial role in controlling growth and development of the fetus. The placenta acts as an interface between the growing child and its environment, the mother. Nutritions, toxins and any environmental challenge of the pregnant mother act on the newborn via the placenta. Moreover, the placenta also produces specific hormones affecting both the mother and the growing child [5] . The placenta itself develops within several weeks from pluripotent cells to a highly differentiated organ. Its epigenome is critical for normal placental function [6] , and plays an important role in programming events occurring during early phases of pregnancy. After fertilisation, both paternal and maternal genomes undergo demethylation [7] . Establishment of correct epigenetic patterns in the trophoblast is crucial for the formation of the fetal side of the placenta and epigenetic factors play an important role in placental maturation and development [8] . It is known that placental function can be influenced by the environment throughout pregnancy, thereby impacting on the appropriate genetic programming needed to allow for proper fetal growth [4] . Exposure to environmental toxins and nutrition during pregnancy may alter DNA methylation of the placenta and subsequently placental function [9] [10] [11] . As a result this, can also trigger epigenetic changes in the offspring, ultimately altering its phenotype [12] . It is believed that these epigenetic alterations lead to a stable reset of key endocrine and structural properties of the offspring, thus potentially causing disease in later life [13] .
DNA methylation, which is the best understood DNA epigenetic modification, may provide an attractive mechanism linking environmental cues to placental pathology, with consequences for fetal growth and adult life [4] . Methylation in vertebrate DNA is, in general, restricted to cytosine (C) nucleotides in the sequence Cytosin-Guanin (annotated CpG). The overall frequency of CpG dinucleotides in the vertebrate genome is low, but there are small stretches of DNA that are characterized by having CpG dinucleotides, extending for hundreds of bases, termed CpG islands [14] [15] [16] . The methylation status of cytosine residues, within CpG dinucleotides and in the context of CpG islands, provides an important mechanism for controlling gene expression activity [14, 16, 17] . Changes in the methylation status (hyper-or hypomethylation) have been associated with various health conditions including malignancies [18] . Besides affecting gene specific methylation patterns [11, 12] , recent studies demonstrated that environmental cues impact on the global methylation status of the placenta [9] [10] [11] 19] . To shed more light on the consequences of this phenomenon, it is important to analyze the degree of placental DNA methylation in large clinical studies in relationship to clinical readouts. For doing so, the establishment of a suitable method to quantify placental DNA methylation is thus urgently needed. In the current study, we developed a reliable method to quantify DNA methylation in the human placenta based on previous work by Song and colleagues [20] .
Materials and Methods
Clinical study
We used 248 placenta samples collected as part of the Berlin Birth Cohort study [21] [22] [23] . The study was approved by the local ethics committee. Biometric data of the newborn were measured during the routine
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Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry postnatal examination. Gestational age at delivery was based on last menstrual period, anamnestically assessed during the first pregnancy examination. The following data of the newborn were added to the database: birth weight, birth length, head circumference, ponderal index, child sex, Apgar score 5 minutes postnatally, Apgar score 10 minutes postnatally and umbilical blood pH levels. Fetal blood was collected from the umbilical cord. Midwives collected maternal blood from a cubital vein in the delivery room or on the ward. Placenta was collected and frozen at -20°C immediately after the placenta was born.
Analysis of DNA Methylation
The deoxyribonucleosides 2`-deoxyguanosine (dG) monohydrate, 5-methyl-2`-deoxycytidine (5mdC) and 2`-deoxycytidine (dC) were purchased from ABCR (Karlsruhe, Germany). Hering sperm DNA was obtained from Sigma-Aldrich (Hamburg, Germany). Nuclease-free water for DNA extraction was purchased from Roth (Karlsruhe, Germany). LC-MS-grade water, methanol and formic acid were purchased from VWR international, Inc. (Dresden, Germany).
Preparation of stock solutions and calibration standards
Stock solutions of the standards were prepared by dissolving each analyte in LCMS-grade water at a concentration of 5 mM. All solutions were prepared freshly before analysis. The stock standard solutions were further diluted with water to yield the calibration standard concentrations of 0.05, 0.1, 0.5, 1, 2. DNA extraction and hydrolysis DNA was extracted using a QIAamp DNA Mini Kit from Qiagen (Hilden, Germany) together with an RNase A digestion according to the manufacturer`s protocol. The content and purity of the collected RNAfree DNA was assessed spectrophotometrically at 230, 260 and 280 nm. Enzymatic DNA hydrolysis was performed using DNA Degradase Plus from Zymo Research (Freiburg, Germany). Briefly, 1 µg of genomic DNA was mixed with 2.5 µL 10X DNA Degradase Reaction Buffer, 1 µL DNA Degradase Plus and filled up with water to a volume of 25 µL. After 4 h at 37 °C the DNA digestion was stopped by adding 75 µL of 0.1% formic acid. As a control 200 ng of the digested DNA was analyzed by agarose gel electrophoresis. 70 µL DNA hydrolysis samples were further diluted with 280 µL 0.1% formic acid to yield a final concentration of 2 ng digested DNA/µL.
LC-ESI-MS/MS Procedure
LC analysis was performed with an Agilent 1200 series HPLC system connected to an Agilent 6530 Accurate-Mass Q-TOF instrument with Jet Stream-Interface (Palo Alto, USA). For chromatographic separation a Waters (Milford, MA) X-Bridge TM C18 4.6 mm x 150 mm (3.5 µm particle size) protected by a Waters X-Bridge TM C18 4.6 mm x 20 mm guard column (5 µm particle size) was used. 0.1% formic acid in water (solvent A) and 0.1 % formic acid in methanol (solvent B) were chosen as mobile phases. The linear gradient elution was 4-20% of solvent B in 10 min at a constant flow rate of 0.5 mL/min. 50 µL diluted DNA hydrolysis samples were injected, typically containing 100 ng digested DNA. The optimized ESI-MS/ MS parameters in positive ion mode were as follows: gas temperature, 250 °C; drying gas flow, 8 L/min; nebulizer pressure, 60 psig; sheat gas temperature, 300 °C; capillary voltage 4000 V; collision energy 7 V for dC, 13 V for 5mdC and 10 V for dG. Quantification was accomplished in multiple reaction monitoring (MRM) mode by monitoring a transition pair of m/z 228.0979/112.0505 for dC, m/z 242.1135/126.0662 for 5mdC and m/z 268.1040/152.0780 for dG, which was used as an internal standard for the measurement. The scan time was 333 ms for each pair.
Percentage of methylation
The percentage of methylation was calculated as: Methylation % = [5mdC]/[dG] according to the calibration curve.
Putra et al.: DNA Methylation Levels in Human Placenta
Cellular Physiology and Biochemistry Figure 1A shows the full-scan spectrum (ESI-MS-spectrum) of a standard solution of 5mdC. With the optimized ESI-conditions only one protonated [M+H] + adduct of 5mdC is detectable at m/z 242.1135. No [M+Na] + but an [2M+H] + adduct occurred, having a sensitivity less than 3% of the main adduct. Figure 1B reports the product ion spectrum of 5mdC (m/z 242.1135). It can be found after the fragmentation, when the main [M+H] + adduct of 5mdC appears at m/z 126.0662. This ion originates due to the cleavage of the N-glycoside bond and transfer of a hydrogen atom from the sugar molecule [24] . Because these findings are comparable to the detection of dC and dG, the precursor/product ion pairs of m/z 228.0979/112.0505 for dC, m/z 242.1135/126.0662 for 5mdC and m/z 268.1040/152.0780 for dG were used as MRM transitions.
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Results and Discussion
Method development and validation Optimization of HPLC-ESI-MS/MS conditions
For high-sensitivity ESI-MS/MS measurements the ESI conditions were first optimized for the [M+H] + adduct of 5mdC, as shown in Figure 1A .
RNA contamination
Interference from RNA contamination poses a potential problem in the analysis of genomic DNA methylation [20] . In order to prevent those interferences, a sufficient DNA purification procedure with removal of RNA was chosen. In addition, an optimized gradient elution program with 0.1% formic acid in water and 0.1% formic acid in methanol was used to separate uracil and 5dmC, which typically elute at the same time. Figure 2 illustrates no interference of 5mdC with uracil. 
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Calibration curves and sensitivity Figure 3 shows a typical calibration curve of 5mdC. The limit of detection (LOD) of 5mdC (S/N = 3) was determined to be 10 fmol. The limit of quantification (LOQ) of 5mdC (S/N = 10) was found to be 50 fmol.
Calculation of genomic DNA methylation
Using an isotope labeled internal standard is one of the most accurate measurements of the methylation level in genomic DNA [25] . But it would get lost during sample preparation, where spin columns are used, which only adsorbs whole DNA molecules. Therefore usually, the global level of methylation is calculated as [5mdC]/([5mdC] + [dC]) using dC as internal standard. Since many modifications of dC are described, we decided to use the more stable dG instead, based on the assumption that in genomic DNA [dG] = [5mdC] + [dC] [20] . We calculated the grade of methylation in DNA as [5mdC]/[dG] and injected 100 ng of digested DNA, which conforms to ~ 20 pmol dG. For this reason calibration curves were prepared to imitate DNA hydrolysis products with 20 pmol of dG, dC and 0.5, 1, 2.5, 5 and 10% [5mdC]/ [dG], as typically 2-6% of the mammalian DNA is methylated [26] . 2 . A gradient elution program with 0.1% formic acid in water and 0.1% formic acid in methanol was used to separate uracil and 5dmC, which elute at the same time. There were no interference of 5mdC with uracil. Fig. 3 . Typical calibration curve of 5mdC. The limit of detection (LOD) of 5mdC (S/N = 3) was determined to be 10 fmol. The limit of quantification (LOQ) of 5mdC (S/N = 10) was found to be 50 fmol.
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Accuracy, intra-day precision and robustness Accuracy, intra-day precision and robustness of the LC-ESI-MS/MS method were assessed by measuring calibration curves and herring sperm DNA on five different days. Intra-day precision was determined by repeated analysis of standard curves at different Tables 1 and 2 ). The time interval between two different sample injections was 20 minutes. As the actual sample measurement is an automated process, this method is suitable for large sample sizes.
Clinical data
The results of the analysis of 248 placenta samples from the BBC study cohort [21] [22] [23] are shown in Fgure 5A. The degree of DNA methylation ranges from 2% to 5 %. This high variability of DNA methylation is remarkable given the fact that this tissue is just 9 months old. Epigenetic alterations are thought to be acquired upon environmental challenges. This may indicate that differences in environmental toxic and/or nutritional exposure of pregnant women translated into epigenetic modulation of the overall placenta DNA methylation degree. If DNA methylation is present in promoters of genes that control key placenta function, differences in DNA methylation should result in differences in the offspring`s phenotype. This should be addressed in future larger studies being adequately powered for such questions. In any case, it is important to note that the degree of placental DNA methylation varies substancially although the age of the tissue is just 9 months. Two ways of calculating the methylation degree are shown in Figure 5A and 5B. We suggest calculating the degree of DNA methylation as dmC/dG, because many modifications of dC are described and dG is more stable. This is justified by the assumption that in genomic DNA [dG] = [5mdC] + [dC] [20] .
Conclusions
In conclusion, High Performance Liquid Chromatography-Electrospray Tandem Mass Spectrometry (HPLC-ESI-MS/MS) based quantification of the dmC/dG ratio is a reliable, stable method to determine global DNA methylation in large clinical trials. The degree of DNA methylation varies substantially in the human placenta. The clinical implications need to be demonstrated in adequately powered studies. Environmental challenges in early life seem to affect multiple (hundreds) of genes. This explains why we could detect such differences in global DNA methylation in our cohort. It is unclear so far whether the pattern of global DNA methylation is different upon different environmental stimuli. We believe that this might be the case, since different environmental stimuli cause different phenotypes in the offspring (1) (2) (3) . Studies in the future need to test this hypothesis. We suggest that the method described here is a suitable screening method to decide whether or not an environmental challenge in early life may cause fetal programming. If this is the case, not yet existing methods needs to be applied to describe the most likely very complex patterns of DNA methylation.
